Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Pernix Therapeutics Holdings, Inc.
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-168877, No. 333-167327, No. 333-166062 and No. 333-175992), Form S-4 (No. 333-200042) and Forms S-3 (No. 333-186048, No. 333-174629, No. 333-200005, and No. 333-200011) of Pernix Therapeutics Holdings, Inc. of our reports dated March 2, 2015, relating to the consolidated balance sheets of the Company as of December 31, 2014 and 2013, and the related consolidated statements of loss, comprehensive income (loss), stockholders’ equity, and cash flows and the related consolidated statement schedule for each of the three years in the period ending December 31, 2014, and the effectiveness of internal control over financial reporting for the Company as of December 31, 2014.
/s/ Cherry Bekaert LLP
Atlanta, Georgia
March 2, 2015